Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis

Background Urinary parameters, anti-dsDNA antibodies and complement tests were explored in patients with childhood-Systemic Lupus Erythematosus (cSLE) early-onset lupus nephritis (ELN) from a large multicenter cohort study. Methods Clinical and laboratory features of cSLE cases with kidney involvement at presentation, were reviewed. Disease activity parameters including SLEDAI-2 K scores and major organ involvement at onset and follow up, with accrued damage scored by SLICC-DI, during last follow up, were compared with those without kidney involvement. Autoantibodies, renal function and complement tests were determined by standard methods. Subjects were grouped by presence or absence of ELN. Results Out of the 846 subjects enrolled, mean age 11.6 (SD 3.6) years; 427 (50.5%) had ELN. There was no significant difference in the ELN proportion, according to onset age, but ELN frequency was significantly higher in non-Caucasians (p = 0.03). Hematuria, pyuria, urine casts, 24-h proteinuria and arterial hypertension at baseline, all had significant association with ELN outcome (p < 0.001). With a similar follow up time, there were significantly higher SLICC-DI damage scores during last follow up visit (p = 0.004) and also higher death rates (p < 0.0001) in those with ELN. Low C3 (chi-square test, p = 0.01), but not C3 levels associated significantly with ELN. High anti-dsDNA antibody levels were associated with ELN (p < 0.0001), but anti-Sm, anti-RNP, anti-Ro, anti-La antibodies were not associated. Low C4, C4 levels, low CH50 and CH50 values had no significant association. High erythrocyte sedimentation rate (ESR) was associated with the absence of ELN (p = 0.02). Conclusion The frequency of ELN was 50%, resulting in higher morbidity and mortality compared to those without ELN. The urinary parameters, positive anti-dsDNA and low C3 are reliable for discriminating ELN.

Palavras-chave

Anti-dsDNA antibodies, Childhood-onset systemic lupus erythematosus, Complement, C3, C4, Lupus nephritis

URI

https://observatorio.fm.usp.br/handle/OPI/35493

Referências

Ambrose N, 2016, LUPUS, V25, P1542, DOI 10.1177/0961203316644333
Bundhun PK, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008086
Chan James C M, 2002, Pediatr Rev, V23, P47, DOI 10.1542/pir.23-2-47
Frankovich JD, 2012, LUPUS, V21, P421, DOI 10.1177/0961203312437805
Gladman DD, 2002, J RHEUMATOL, V29, P288
Gomes RC, 2016, ARTHRIT CARE RES, V68, P1736, DOI 10.1002/acr.22881
Hiraki LT, 2008, J PEDIATR-US, V152, P550, DOI 10.1016/j.jpeds.2007.09.019
Hiraki LT, 2011, ARTHRITIS RHEUM-US, V63, P1988, DOI 10.1002/art.30350
Lee PY, 2013, LUPUS, V22, P1534, DOI 10.1177/0961203313502110
Lewandowski LB, 2017, LUPUS, V26, P186, DOI 10.1177/0961203316660625
Marks SD, 2007, PEDIATR NEPHROL, V22, P77, DOI 10.1007/s00467-006-0296-y
Smith EMD, 2018, LUPUS, V27, P2190, DOI 10.1177/0961203318808376
Sutton EJ, 2013, SEMIN ARTHRITIS RHEU, V43, P352, DOI 10.1016/j.semarthrit.2013.05.003
TING CK, 1992, ANN RHEUM DIS, V51, P45, DOI 10.1136/ard.51.1.45
Wakiguchi H, 2017, CLIN RHEUMATOL, V36, P433, DOI 10.1007/s10067-016-3491-7
Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865
Wu JY, 2014, SEMIN ARTHRITIS RHEU, V43, P513, DOI 10.1016/j.semarthrit.2013.07.005

Coleções

Artigos e Materiais de Revistas Científicas - FM/MPE
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/ICr
Artigos e Materiais de Revistas Científicas - LIM/17
Artigos e Materiais de Revistas Científicas - LIM/36

Página do item completo